Loading…
Loading…
EQUITY / NASDAQ · XNCM
CytoMed Therapeutics Ltd.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →01/01/2025 – 12/31/2025 · SGD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.92 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 0.92 USD · Volume 33,742
64 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
01/01/2025 – 12/31/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Revenue | 324,387 SGD | 69,501 SGD | +366.74% |
| Net income | -3,996,336 SGD | -2,521,861 SGD | — |
| Operating cash flow | -3,697,463 SGD | -2,709,929 SGD | — |
| Cash and cash equivalents | 2,095,489 SGD | 4,697,047 SGD | -55.39% |
| Total liabilities | 1,131,286 SGD | 1,023,960 SGD | +10.48% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · SGD | 2024 / Year end01/01/2024 – 12/31/2024ConsolidatedUnits · SGD | 2023 / Year end01/01/2023 – 12/31/2023ConsolidatedUnits · SGD |
|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 2,095,489 SGD | 4,697,047 SGD | 6,224,187 SGD |
| Financing cash flowCash flow statement | 208,648 SGD | -64,892 SGD | 10,919,885 SGD |
| Investing cash flowCash flow statement | 929,283 SGD | 1,126,541 SGD | -2,730,809 SGD |
| Net incomeIncome statement | -3,996,336 SGD | -2,521,861 SGD | -4,133,170 SGD |
| Operating cash flowCash flow statement | -3,697,463 SGD | -2,709,929 SGD | -3,531,196 SGD |
| RevenueIncome statement | 324,387 SGD | 69,501 SGD | — |
| Total assetsBalance sheet | 7,984,953 SGD | 10,067,749 SGD | — |
| Total equityBalance sheet | 6,853,667 SGD | 9,043,789 SGD | 11,244,155 SGD |
| Total liabilitiesBalance sheet | 1,131,286 SGD | 1,023,960 SGD | — |
| Report source | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 03/31/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.